DrugPatentWatch Database Preview
Biologic Patents Expiring in 2039
» See Plans and Pricing
Biologic Patents With Estimated Expirations in 2039
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017016 | 004 | 1975-06-26 | Start Trial | 2039-02-26 | RX | search | ||
| Ferring | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017016 | 004 | 1975-06-26 | Start Trial | Beth Israel Hospital Assn. (Boston, MA) The Brigham and Womens Hospital, Inc. (Boston, MA) | 2039-02-26 | RX | search | |
| Ferring | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017016 | 004 | 1975-06-26 | Start Trial | The United States of America as Represented by the Secretary of the Navy (Washington, DC) U.S. Drug Testing, Inc. (Rancho Cucamonga, CA) | 2039-02-26 | RX | search | |
| Ferring | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017016 | 004 | 1975-06-26 | Start Trial | Betagene, Inc. (Dallas, TX) Board of Regents, The University of Texas System (Austin, TX) | 2039-02-26 | RX | search | |
| Ferring | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017016 | 004 | 1975-06-26 | Start Trial | Pharmaceutical Discovery Corporation (Elmsford, NY) | 2039-02-26 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
